Novartis CEO Says Massive Blockbuster Drugs Are Over


By Max Nisen/Business Insider War Room

Mar 05, 2013

The business model for large pharmaceutical companies hasn't changed for decades. Now, many blockbusters are losing patent protection, huge companies are losing billions in sales to generic competitors, and despite massive research spending, have few new drugs that look like they will replace ones with expiring patents. Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments